Sicart Associates’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-8,300
Closed -$232K 80
2017
Q2
$232K Hold
8,300
0.17% 74
2017
Q1
$255K Sell
8,300
-2,500
-23% -$70.6K 0.18% 81
2016
Q4
$272K Buy
+10,800
New +$255K 0.19% 91

Other funds holding DBD

Sicart Associates's DBD Position: Q3 2017 in Review

Sicart Associates sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2017, closing a stake of 8,300 shares — an estimated $232K sold.

Sicart Associates first reported a position in DBD in Q4 2016 and held it in 3 quarters. The position peaked at $272K in Q4 2016. 226 funds tracked by Wall St. Rank hold DBD as of Q3 2017.

  • Sicart Associates reported no remaining Diebold Nixdorf Incorporated position as of Q3 2017 after selling out during the quarter.
  • Sicart Associates sold 8,300 Diebold Nixdorf Incorporated shares in Q3 2017, an estimated $232K.
  • Sicart Associates first reported a position in Diebold Nixdorf Incorporated in Q4 2016 and held it in 3 quarters.
  • Sicart Associates's Diebold Nixdorf Incorporated position peaked at $272K in Q4 2016.
  • 226 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2017.

Based on Sicart Associates's 13F filing for Q3 2017, filed 6 Nov 2017.